Published in PLoS One on November 14, 2013
The CASTOR Proteins Are Arginine Sensors for the mTORC1 Pathway. Cell (2016) 1.85
Computational study of missense mutations in phenylalanine hydroxylase. J Mol Model (2015) 0.78
Disruption of phenylalanine hydroxylase reduces adult lifespan and fecundity, and impairs embryonic development in parthenogenetic pea aphids. Sci Rep (2016) 0.77
First Case Report of EX3del4765 Mutation in PAH Gene in Asian Population. Iran Red Crescent Med J (2016) 0.75
New protein structures provide an updated understanding of phenylketonuria. Mol Genet Metab (2017) 0.75
VMD: visual molecular dynamics. J Mol Graph (1996) 117.02
Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers (1983) 99.69
Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol (1993) 64.61
GROMACS: fast, flexible, and free. J Comput Chem (2005) 27.22
Essential dynamics of proteins. Proteins (1993) 11.56
Gleaning non-trivial structural, functional and evolutionary information about proteins by iterative database searches. J Mol Biol (1999) 5.90
Phenylketonuria. Lancet (2010) 3.58
Structural basis of autoregulation of phenylalanine hydroxylase. Nat Struct Biol (1999) 2.67
The ACT domain: a small molecule binding domain and its role as a common regulatory element. J Biol Chem (2006) 1.96
A global model of the protein-solvent interface. Biophys J (1994) 1.73
The essential dynamics of thermolysin: confirmation of the hinge-bending motion and comparison of simulations in vacuum and water. Proteins (1995) 1.70
A simple purification of phenylalanine hydroxylase by substrate-induced hydrophobic chromatography. J Biol Chem (1979) 1.68
BODIL: a molecular modeling environment for structure-function analysis and drug design. J Comput Aided Mol Des (2004) 1.64
Structure and function of the aromatic amino acid hydroxylases. Biochem J (1995) 1.51
The aromatic amino acid hydroxylases. Adv Enzymol Relat Areas Mol Biol (2000) 1.38
The phenylalanine hydroxylating system. Adv Enzymol Relat Areas Mol Biol (1993) 1.33
Dynamite: a simple way to gain insight into protein motions. Acta Crystallogr D Biol Crystallogr (2004) 1.32
Prion and water: tight and dynamical hydration sites have a key role in structural stability. Proc Natl Acad Sci U S A (2005) 1.30
Structural Insight into the Aromatic Amino Acid Hydroxylases and Their Disease-Related Mutant Forms. Chem Rev (1999) 1.28
Correction of kinetic and stability defects by tetrahydrobiopterin in phenylketonuria patients with certain phenylalanine hydroxylase mutations. Proc Natl Acad Sci U S A (2004) 1.28
Detection of functional modes in protein dynamics. PLoS Comput Biol (2009) 1.27
Geometry-based sampling of conformational transitions in proteins. Structure (2007) 1.26
Distribution function implied dynamics versus residence times and correlations: solvation shells of myoglobin. Proteins (1994) 1.24
Predicted effects of missense mutations on native-state stability account for phenotypic outcome in phenylketonuria, a paradigm of misfolding diseases. Am J Hum Genet (2007) 1.24
Elucidating the inhibition mechanism of HIV-1 non-nucleoside reverse transcriptase inhibitors through multicopy molecular dynamics simulations. J Mol Biol (2009) 1.21
L-phenylalanine binding and domain organization in human phenylalanine hydroxylase: a differential scanning calorimetry study. Biochemistry (2002) 1.20
Regulation of phenylalanine hydroxylase: conformational changes upon phenylalanine binding detected by hydrogen/deuterium exchange and mass spectrometry. Biochemistry (2010) 1.12
Allosteric mechanisms in ACT domain containing enzymes involved in amino acid metabolism. Amino Acids (2005) 1.11
The structural basis of phenylketonuria. Mol Genet Metab (1999) 1.10
Ligand-dependent conformations and dynamics of the serotonin 5-HT(2A) receptor determine its activation and membrane-driven oligomerization properties. PLoS Comput Biol (2012) 1.10
Structure/function relationships in human phenylalanine hydroxylase. Effect of terminal deletions on the oligomerization, activation and cooperativity of substrate binding to the enzyme. Eur J Biochem (1996) 1.09
Direct evidence for a phenylalanine site in the regulatory domain of phenylalanine hydroxylase. Arch Biochem Biophys (2010) 1.08
Loss of function in phenylketonuria is caused by impaired molecular motions and conformational instability. Am J Hum Genet (2008) 1.02
Structures of open (R) and close (T) states of prephenate dehydratase (PDT)--implication of allosteric regulation by L-phenylalanine. J Struct Biol (2007) 0.99
Phosphorylation and mutations of Ser(16) in human phenylalanine hydroxylase. Kinetic and structural effects. J Biol Chem (2002) 0.97
PKU mutation G46S is associated with increased aggregation and degradation of the phenylalanine hydroxylase enzyme. Hum Mutat (1996) 0.97
Phenylketonuria missense mutations in the Mediterranean. Genomics (1991) 0.97
Molecular dynamics-based approaches for enhanced sampling of long-time, large-scale conformational changes in biomolecules. F1000 Biol Rep (2009) 0.96
Missense mutations in the N-terminal domain of human phenylalanine hydroxylase interfere with binding of regulatory phenylalanine. Am J Hum Genet (2001) 0.95
Activation of phenylalanine hydroxylase: effect of substitutions at Arg68 and Cys237. Biochemistry (2003) 0.95
Severity of mutation in the phenylalanine hydroxylase gene influences phenylalanine metabolism in phenylketonuria and hyperphenylalaninaemia heterozygotes. J Inherit Metab Dis (1994) 0.93
Phenylketonuria as a protein misfolding disease: The mutation pG46S in phenylalanine hydroxylase promotes self-association and fibril formation. Biochim Biophys Acta (2010) 0.86
Functional and structural characterization of novel mutations and genotype-phenotype correlation in 51 phenylalanine hydroxylase deficient families from Southern Italy. FEBS J (2009) 0.85
Searching distant homologs of the regulatory ACT domain in phenylalanine hydroxylase. Amino Acids (2008) 0.84
In vitro expression of 34 naturally occurring mutant variants of phenylalanine hydroxylase: correlation with metabolic phenotypes and susceptibility toward protein aggregation. Mol Genet Metab (2001) 0.84
Activation of phenylalanine hydroxylase induces positive cooperativity toward the natural cofactor. J Biol Chem (2010) 0.82
Protein-water interactions in MD simulations: POPS/POPSCOMP solvent accessibility analysis, solvation forces and hydration sites. Methods Mol Biol (2012) 0.81
Reversal of metabolic and neurological symptoms of phenylketonuric mice treated with a PAH containing helper-dependent adenoviral vector. Curr Gene Ther (2012) 0.81
A structural hypothesis for BH4 responsiveness in patients with mild forms of hyperphenylalaninaemia and phenylketonuria. J Inherit Metab Dis (2001) 0.80
Natural phenylalanine hydroxylase variants that confer a mild phenotype affect the enzyme's conformational stability and oligomerization equilibrium. Biochim Biophys Acta (2011) 0.80
Five human phenylalanine hydroxylase proteins identified in mild hyperphenylalaninemia patients are disease-causing variants. Biochim Biophys Acta (2008) 0.78
Mutation of the RAD51C gene in a Fanconi anemia-like disorder. Nat Genet (2010) 3.57
Genetic modifiers of liver disease in cystic fibrosis. JAMA (2009) 1.88
Combined CD133/CD44 expression as a prognostic indicator of disease-free survival in patients with colorectal cancer. Arch Surg (2012) 1.86
RNA-dependent oligomerization of APOBEC3G is required for restriction of HIV-1. PLoS Pathog (2009) 1.84
POPS: A fast algorithm for solvent accessible surface areas at atomic and residue level. Nucleic Acids Res (2003) 1.69
A validated HPLC stability-indicating method for the determination of diacerhein in bulk drug substance. J Pharm Biomed Anal (2005) 1.63
Lessons to be learned from the clinical management of a MEN 2A patient bearing a novel 634/640/700 mutation of the RET proto-oncogene. Clin Endocrinol (Oxf) (2012) 1.60
A pH-regulated quality control cycle for surveillance of secretory protein assembly. Mol Cell (2013) 1.60
Ischemic neoangiogenesis enhanced by beta2-adrenergic receptor overexpression: a novel role for the endothelial adrenergic system. Circ Res (2005) 1.57
Crystal structure of the collagen triple helix model [(Pro-Pro-Gly)(10)](3). Protein Sci (2002) 1.36
Detection of allosteric signal transmission by information-theoretic analysis of protein dynamics. FASEB J (2011) 1.36
Prion and water: tight and dynamical hydration sites have a key role in structural stability. Proc Natl Acad Sci U S A (2005) 1.30
B-RAF mutant alleles associated with Langerhans cell histiocytosis, a granulomatous pediatric disease. PLoS One (2012) 1.29
Crystal structure of the alcohol dehydrogenase from the hyperthermophilic archaeon Sulfolobus solfataricus at 1.85 A resolution. J Mol Biol (2002) 1.17
Josephin domain of ataxin-3 contains two distinct ubiquitin-binding sites. Biopolymers (2009) 1.17
Identification and functional characterization of malignant hyperthermia mutation T1354S in the outer pore of the Cavalpha1S-subunit. Am J Physiol Cell Physiol (2010) 1.17
AKT participates in endothelial dysfunction in hypertension. Circulation (2004) 1.15
Novel synthetic, salt-resistant analogs of human beta-defensins 1 and 3 endowed with enhanced antimicrobial activity. Antimicrob Agents Chemother (2010) 1.14
Physical aspects of protein crystal growth investigated with the Advanced Protein Crystallization Facility in reduced-gravity environments. Acta Crystallogr D Biol Crystallogr (2002) 1.10
The oligomerization properties of prion protein are restricted to the H2H3 domain. FASEB J (2010) 1.08
Hydrogen-bonding propensities of sphingomyelin in solution and in a bilayer assembly: a molecular dynamics study. Biophys J (2003) 1.08
Plasticity of influenza haemagglutinin fusion peptides and their interaction with lipid bilayers. Biophys J (2004) 1.06
An altered gut microbiome profile in a child affected by Crohn's disease normalized after nutritional therapy. Am J Gastroenterol (2013) 1.06
Crystal structure of a ternary complex of the alcohol dehydrogenase from Sulfolobus solfataricus. Biochemistry (2003) 1.06
A targeted siRNA screen identifies regulators of Cdc42 activity at the natural killer cell immunological synapse. Sci Signal (2011) 1.05
Molecular interactions of ASPP1 and ASPP2 with the p53 protein family and the apoptotic promoters PUMA and Bax. Nucleic Acids Res (2008) 1.03
Correlation between omega and psi dihedral angles in protein structures. J Mol Biol (2005) 1.03
BCR/ABL genes and leukemic phenotype: from molecular mechanisms to clinical correlations. Oncogene (2002) 1.00
POPSCOMP: an automated interaction analysis of biomolecular complexes. Nucleic Acids Res (2005) 1.00
Structural and hydration properties of the partially unfolded states of the prion protein. Biophys J (2007) 0.99
Glucokinase gene mutations: structural and genotype-phenotype analyses in MODY children from South Italy. PLoS One (2008) 0.98
How Förster resonance energy transfer imaging improves the understanding of protein interaction networks in cancer biology. Chemphyschem (2011) 0.98
Butyrate as an effective treatment of congenital chloride diarrhea. Gastroenterology (2004) 0.98
Neutrophilic-chronic myeloid leukemia: low levels of p230 BCR/ABL mRNA and undetectable BCR/ABL protein may predict an indolent course. Cancer (2002) 0.98
Structural alphabets derived from attractors in conformational space. BMC Bioinformatics (2010) 0.97
Protein cross-talk in CD133+ colon cancer cells indicates activation of the Wnt pathway and upregulation of SRp20 that is potentially involved in tumorigenicity. Proteomics (2012) 0.96
Haemophilia A: molecular insights. Clin Chem Lab Med (2007) 0.96
MinSet: a general approach to derive maximally representative database subsets by using fragment dictionaries and its application to the SCOP database. Bioinformatics (2007) 0.95
Large-scale modelling of the divergent spectrin repeats in nesprins: giant modular proteins. PLoS One (2013) 0.95
Carotid artery remodeling in middle-aged women with the metabolic syndrome (from the "Progetto ATENA" study). Am J Cardiol (2005) 0.94
Protein networks reveal detection bias and species consistency when analysed by information-theoretic methods. PLoS One (2010) 0.92
Development of new laccases by directed evolution: functional and computational analyses. Proteins (2008) 0.91
Toward the understanding of MNEI sweetness from hydration map surfaces. Biophys J (2006) 0.91
Molecular response to imatinib in late chronic-phase chronic myeloid leukemia. Blood (2003) 0.91
CD66c is a novel marker for colorectal cancer stem cell isolation, and its silencing halts tumor growth in vivo. Cancer (2012) 0.91
Microbial diversity in natural whey cultures used for the production of Caciocavallo Silano PDO cheese. Int J Food Microbiol (2008) 0.91
Structural basis for substrate specificity in group I nucleoside hydrolases. Biochemistry (2008) 0.91
Comprehensive mutation analysis (20 families) of the choroideremia gene reveals a missense variant that prevents the binding of REP1 with Rab geranylgeranyl transferase. Hum Mutat (2011) 0.90
Decreased paraoxonase-2 expression in human carotids during the progression of atherosclerosis. Arterioscler Thromb Vasc Biol (2008) 0.90
Hepatitis B virus reactivation after fludarabine-based regimens for indolent non-Hodgkin's lymphomas: high prevalence of acquired viral genomic mutations. Haematologica (2003) 0.89
Lessons from crystals grown in the Advanced Protein Crystallisation Facility for conventional crystallisation applied to structural biology. Biophys Chem (2005) 0.89
Distribution of human beta-defensin polymorphisms in various control and cystic fibrosis populations. Genomics (2005) 0.89
Transcription factor TBX1 overexpression induces downregulation of proteins involved in retinoic acid metabolism: a comparative proteomic analysis. J Proteome Res (2009) 0.89
Reorganization in apo- and holo-beta-lactoglobulin upon protonation of Glu89: molecular dynamics and pKa calculations. Proteins (2004) 0.89
Reversible substrate-induced domain motions in ribonuclease A. Proteins (2002) 0.89
Imino acids and collagen triple helix stability: characterization of collagen-like polypeptides containing Hyp-Hyp-Gly sequence repeats. J Am Chem Soc (2004) 0.89
Glucokinase (GCK) mutations and their characterization in MODY2 children of southern Italy. PLoS One (2012) 0.89
Denaturing HPLC procedure for factor IX gene scanning. Clin Chem (2003) 0.88
The crystal structure of a tetrameric hemoglobin in a partial hemichrome state. Proc Natl Acad Sci U S A (2002) 0.88
SRp20: an overview of its role in human diseases. Biochem Biophys Res Commun (2013) 0.87
Rationalisation of the differences between APOBEC3G structures from crystallography and NMR studies by molecular dynamics simulations. PLoS One (2010) 0.87
The p73 DNA binding domain displays enhanced stability relative to its homologue, the tumor suppressor p53, and exhibits cooperative DNA binding. Biochemistry (2008) 0.87
Hereditary fructose intolerance: functional study of two novel ALDOB natural variants and characterization of a partial gene deletion. Hum Mutat (2010) 0.87
Therapeutic angiogenesis in diabetic apolipoprotein E-deficient mice using bone marrow cells, functional hemangioblasts and metabolic intervention. Atherosclerosis (2009) 0.87
Quality of Life (QoL) assessment in a cohort of patients with phenylketonuria. BMC Public Health (2014) 0.86
Interaction of malaria parasite-inhibitory antibodies with the merozoite surface protein MSP1(19) by computational docking. Proteins (2007) 0.86
A mannose-binding lectin-defective haplotype is a risk factor for gastric cancer. Clin Chem (2006) 0.86
The crystal structure of Sulfolobus solfataricus elongation factor 1alpha in complex with magnesium and GDP. Biochemistry (2004) 0.86
Structural study of a single-point mutant of Sulfolobus solfataricus alcohol dehydrogenase with enhanced activity. FEBS Lett (2003) 0.86
Polyproline helices in protein structures: A statistical survey. Protein Pept Lett (2006) 0.85
Functional and structural characterization of novel mutations and genotype-phenotype correlation in 51 phenylalanine hydroxylase deficient families from Southern Italy. FEBS J (2009) 0.85
Implicit Solvation Parameters Derived from Explicit Water Forces in Large-Scale Molecular Dynamics Simulations. J Chem Theory Comput (2012) 0.85
Cytometric and biochemical characterization of human breast cancer cells reveals heterogeneous myoepithelial phenotypes. Cytometry A (2012) 0.85
GSATools: analysis of allosteric communication and functional local motions using a structural alphabet. Bioinformatics (2013) 0.85
A paraoxonase gene polymorphism, PON 1 (55), as an independent risk factor for increased carotid intima-media thickness in middle-aged women. Atherosclerosis (2003) 0.85
Haemophilia B: from molecular diagnosis to gene therapy. Clin Chem Lab Med (2003) 0.85
Chimeric beta-defensin analogs, including the novel 3NI analog, display salt-resistant antimicrobial activity and lack toxicity in human epithelial cell lines. Antimicrob Agents Chemother (2013) 0.85
Mutants of the tumour suppressor p53 L1 loop as second-site suppressors for restoring DNA binding to oncogenic p53 mutations: structural and biochemical insights. Biochem J (2010) 0.84
A structural overview of the vertebrate prion proteins. Prion (2007) 0.84
Dynamic domain threading. Proteins (2006) 0.84
Altered brain protein expression profiles are associated with molecular neurological dysfunction in the PKU mouse model. J Neurochem (2014) 0.84
Structural and functional analysis of aldolase B mutants related to hereditary fructose intolerance. FEBS Lett (2002) 0.84
Thermal unfolding simulations of apo-calmodulin using leap-dynamics. Proteins (2003) 0.84
Six novel alleles identified in Italian hereditary fructose intolerance patients enlarge the mutation spectrum of the aldolase B gene. Hum Mutat (2004) 0.84
Quality assessment in cytogenetic and molecular genetic testing: the experience of the Italian Project on Standardisation and Quality Assurance. Clin Chem Lab Med (2004) 0.83
Conformation and dynamics of a rhodamine probe attached at two sites on a protein: implications for molecular structure determination in situ. J Am Chem Soc (2008) 0.83
Functional analysis of melanocortin-4-receptor mutants identified in severely obese subjects living in Southern Italy. Gene (2010) 0.83
Specialized Dynamical Properties of Promiscuous Residues Revealed by Simulated Conformational Ensembles. J Chem Theory Comput (2013) 0.83
A case-by-case evolutionary analysis of four imprinted retrogenes. Evolution (2011) 0.83
Structure and stability of a thioredoxin reductase from Sulfolobus solfataricus: a thermostable protein with two functions. Biochim Biophys Acta (2008) 0.83
Proteomic Profiling of a Biomimetic Drug Delivery Platform. Curr Drug Targets (2015) 0.83
Calcium regulates scallop muscle by changing myosin flexibility. Eur Biophys J (2006) 0.83